A Randomized, Double-Blind, Vehicle Controlled Study To Evaluate The Safety, Tolerability, And Efficacy Of DMT210 Gel In Adult Patients With Moderate To Severe Acne Rosacea
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2017
At a glance
- Drugs DMT 200 (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors Dermata Therapeutics
- 10 Jun 2017 Biomarkers information updated
- 07 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 18 Jan 2017 According to Dermata Therapeutics media release, first patient has been dosed in the study and top line results are expected in the second half of 2017.